CN Stock MarketDetailed Quotes
300254 Shanxi C&Y Pharmaceutical Group
- 9.43
- +0.06+0.64%
Market Closed Nov 29 15:00 CST
2.34BMarket Cap28.23P/E (TTM)
9.59High9.18Low109.08KlotVolume9.36Open9.37Pre Close102.71MTurnover4.85%Turnover Ratio93.37P/E (Static)248.32MShares11.8652wk High3.62P/B2.12BFloat Cap4.9852wk Low11.24Limit Up225.02MShs Float54.40Historical High7.50Limit Down4.38%Amplitude4.72Historical Low--Dividend TTM9.42Avg Price59.44KlotAsk--Div YieldTTM100Lot Size47.43KlotBid
Shanxi C&Y Pharmaceutical Group Key Stats
EPS
According to the latest financial report of Shanxi C&Y Pharmaceutical Group, the latest earnings per share (TTM) for the company is 0.18. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Shanxi C&Y Pharmaceutical Group's latest financial report to see how much their book value per share (BVPS) is currently at 2.61.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Shanxi C&Y Pharmaceutical Group shows that the company's current ratio is 0.84, indicating healthy liquidity.
Currency: CNY
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Shanxi C&Y Pharmaceutical Group, the quick ratio is 0.64, indicating that the company can meet its short-term debt obligations.
Currency: CNY
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Shanxi C&Y Pharmaceutical Group? The latest ROE figure is 7.07%, indicating that the company has stable profitability.
Currency: CNY
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Shanxi C&Y Pharmaceutical Group, the total asset return on investment (ROA) is 4.54%.
Currency: CNY
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Shanxi C&Y Pharmaceutical Group's latest financial report to see how their gross margin is doing - currently at 66.99%.
Currency: CNY
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Shanxi C&Y Pharmaceutical Group, the net profit margin is 11.03%, which is a good sign for its profitability.
Currency: CNY
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data